Skip to main content

Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy

Access & Citations

  • 518
    Article Accesses
  • 0
    Web of Science
  • 0

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.